[topsearch__bar__shortcode]

December 23, 2021

Advaxis, Inc. (ADXS) Stock Declining in the After Market. Here’s What you Should Know

Advaxis, Inc. (ADXS) is a leading biopharmaceutical company which primarily focuses on the development and marketing of Listeria monocytogenes (Lm) based antigen delivery products for the treatment of tumors. One of the lead product candidates of the company is ADXS-PSA which is a Phase 2 clinical trial treatment for metastatic prostate cancer. Other products are

Advaxis, Inc. (ADXS) Stock Declining in the After Market. Here’s What you Should Know Read More »